Trials / Completed
CompletedNCT01484288
Baroreflex Activation Therapy in Heart Failure
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- CVRx, Inc. · Industry
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this clinical investigation is to evaluate the efficacy and safety of the CVRx Barostim Neo System in the treatment of patients with heart failure.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Barostim Neo System | Baroreflex Activation Therapy using the Barostim Neo System |
Timeline
- Start date
- 2011-11-01
- Primary completion
- 2013-07-01
- Completion
- 2015-03-01
- First posted
- 2011-12-02
- Last updated
- 2021-08-26
- Results posted
- 2021-08-26
Locations
1 site across 1 country: Italy
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT01484288. Inclusion in this directory is not an endorsement.